Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: six month results of a randomized trial

Eur Heart J. 2003 Mar;24(5):421-9. doi: 10.1016/s0195-668x(02)00701-7.

Abstract

Study objective: To compare the long-term angiographic, clinical and economic outcome of direct stenting vs stenting after balloon predilatation.

Patient population and methods: Four hundred patients with coronary stenoses in a single native vessel were randomized to direct stenting vs stenting after predilatation. A major adverse cardiac and cerebral event (MACCE) was defined as death, myocardial infarction, stent thrombosis, target restenosis, repeat target- and non-target vessel-related percutaneous coronary intervention, target lesion revascularization, coronary artery bypass surgery and stroke.

Results: Stents were successfully implanted in 98.3% of patients randomized to direct stenting vs 97.8% randomized to stenting preceded by predilatation. The primary success rate of direct stenting was 88.3%, vs 97.8% for stenting preceded by balloon dilatation (P=0.01). The angiographic follow-up at 6 months included 333 of the 400 patients (83%). The binary in-stent restenosis rate was 23.1% of 163 patients randomized to direct stenting vs 18.8% of 166 patients randomized to balloon predilatation (P=0.32). By 185+/-25 days, MACCE had occurred in 31 of 200 (15.5%) patients randomized to direct stenting, vs 33 of 200 (16.5%) randomized to predilatation (P=0.89). At 6 months, costs associated with the direct stenting strategy (Euros 3222/patient) were similar to those associated with predilatation (Euros 3428/patient, P=0.43). However, procedural costs were significantly lower. It is noteworthy that, on multivariate analysis, a baseline C-reactive protein level >10 mg l(-1)was a predictor of restenosis (odds ratio: 2.10, P=0.025) as well as of MACCE (odds ratio: 1.94, P=0.045).

Conclusions: Compared to stenting preceded by balloon predilatation, direct stenting was associated with similar 6-month restenosis and MACCE rates. Procedural, but not overall 6-month costs, were reduced by direct stenting. An increased baseline CRP level was an independent predictor of adverse long-term outcome after coronary stent implantation.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Angina Pectoris / economics
  • Angina Pectoris / therapy
  • Catheterization / economics
  • Catheterization / methods
  • Coronary Restenosis / economics
  • Coronary Restenosis / prevention & control*
  • Coronary Stenosis / economics
  • Coronary Stenosis / therapy*
  • Cost-Benefit Analysis
  • Equipment Failure
  • Female
  • Follow-Up Studies
  • Graft Occlusion, Vascular / etiology
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Myocardial Infarction / economics
  • Myocardial Infarction / prevention & control
  • Stents* / economics
  • Stroke / economics
  • Stroke / etiology
  • Stroke / therapy
  • Treatment Outcome